3.
Group | n | TPS | CEA | Pro-GRP | CYFRA21-1 | |||||||
n (%) | Concentration (U/L) | n (%) | Concentration (ng/L) | n (%) | Concentration (pg/mL) | n (%) | Concentration (ng/mL) | |||||
Compared squamous with small cell lung cancer: *P>0.05, **P < 0.05; compared small cell lung cancer with adenocarcinoma: #P>0.05, ##P < 0.05; compared adenocarcinoma with squamous: △P>0.05, △△P < 0.05. | ||||||||||||
Squamous | 20 | 14 (70.0)* | 177.75±137.94* | 3 (15.0)* | 5.06±10.60* | 1 (5.0)** | 47.90±118.85** | 4 (20.0%)** | 1.55±2.22* | |||
Small cell lung cancer | 21 | 12 (57.1)# | 181.67±119.71## | 4 (19.0)# | 9.29±20.21# | 14 (66.7)## | 360.71±416.65## | 0 (0)# | 0.78±0.89# | |||
Adenocarcinoma | 41 | 19 (46.3)△ | 122.91±131.39△△ | 18 (43.9)△△ | 18.62±24.82△△ | 1 (2.4)△ | 20.65±25.00△ | 1 (2.4%)△△ | 1.01±1.16△ |